[No association between catechol-O-methyltransferase val158met polymorphism and alexithymia]

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Context:

• Dopamine pathways in the prefrontal cortex are implicated in alexithymia.
• The COMT gene regulates dopamine degradation and has a common functional polymorphism (Val158Met).
• Previous research links the COMT Val158Met polymorphism to various psychiatric conditions.

Purpose:

• To investigate the association between the COMT Val158Met gene polymorphism and alexithymia.
• To determine if this specific genetic variation contributes to alexithymia in healthy individuals and those with mental disorders.

Summary:

• 120 healthy students and 120 patients with mental disorders were genotyped for the COMT Val158Met polymorphism.
• The Toronto Alexithymia Scale (TAS-20) was used to assess alexithymia levels.
• No significant correlation was found between COMT genotype and TAS-20 scores in either group.

Impact:

• The COMT Val158Met polymorphism alone does not appear to be a primary determinant of alexithymia.
• Findings suggest that other genetic factors, potentially interacting with environmental and developmental influences, may play a more significant role in alexithymia.
• This research contributes to understanding the complex genetic underpinnings of alexithymia.